跳至主要内容
临床试验/NCT04242823
NCT04242823
进行中(未招募)
不适用

Performance of Two-stage Cervical Cancer Screening Algorithms Using Primary High-risk Human Papillomavirus Testing in Botswana

Beth Israel Deaconess Medical Center1 个研究点 分布在 1 个国家目标入组 3,000 人2021年2月22日

概览

阶段
不适用
干预措施
8-type HPV genotype restriction
疾病 / 适应症
Cervical Cancer
发起方
Beth Israel Deaconess Medical Center
入组人数
3000
试验地点
1
主要终点
Determine the persistence of HPV infection in WLHIV at the pre-specified follow-up interval
状态
进行中(未招募)
最后更新
5天前

概览

简要总结

Primary high-risk human papillomavirus (HPV) testing has become first line screening for cervical cancer in high-income countries. The feasibility of this approach in low- and middle-income countries (LMICs) is less clear, as is the role of HPV testing among women living with human immunodeficiency virus (HIV). The proposed study seeks to evaluate the accuracy of cervical cancer screening algorithms using primary HPV testing followed by various forms of visual evaluation, including visual inspection with acetic acid (VIA), colposcopy and HPV genotype restriction for the detection of high-grade cervical dysplasia, using histology as the gold standard. We will validate the AmpFire Assay for HPV self-sampling in our setting. We will evaluate optimal screening intervals in women living with HIV (WLHIV) in an HPV-based cervical cancer screening program and compare triage strategies for positive HPV results at WHO recommended screening intervals for WLHIV. We also seek to understand in-depth the attitudes, acceptability and preferences regarding cervical cancer screening, HPV testing, and self-sampling, for women in Botswana through interviews of a sub-set of women recruited for the cervical cancer screening study. Finally, we will analyze the cost of two-stage cervical cancer screening algorithms using high-risk HPV testing in Botswana.

注册库
clinicaltrials.gov
开始日期
2021年2月22日
结束日期
2027年2月1日
最后更新
5天前
研究类型
Interventional
研究设计
Single Group
性别
Female

研究者

责任方
Principal Investigator
主要研究者

Rebecca Luckett

Obstetrician Gynecologist

Beth Israel Deaconess Medical Center

入排标准

入选标准

  • Cis-gender female or transgender male (must have a cervix)
  • ≥25 years of age
  • Competent to understand study procedures and give informed consent.

排除标准

  • Currently pregnant (as diagnostic procedures for cervical cancer are often deferred during pregnancy)
  • Previous hysterectomy
  • Previous diagnosis of cervical cancer

研究组 & 干预措施

Baseline screening cohort

This group undergoes HPV testing using self-collected swabs. Triage evaluation occurs in all women who test HPV positive which includes visual inspection with acetic acid and colposcopy. The WLHIV in the cohort who test HPV positive at baseline but who have concurrent benign histopathology results will be invited back for re-screening at a 2-year interval, and undergo similar HPV testing and triage procedures. The WLHIV in the cohort who test HPV negative at baseline will be invited back for re-screening at a 3-year interval and undergo similar HPV testing and triage procedures.

干预措施: 8-type HPV genotype restriction

结局指标

主要结局

Determine the persistence of HPV infection in WLHIV at the pre-specified follow-up interval

时间窗: 5 years

Determine the incidence of HPV infection in WLHIV at the pre-specified follow-up interval

时间窗: 5 years

Determine the clearance of HPV infection in WLHIV at the pre-specified follow-up interval

时间窗: 5 years

Quantify the incidence of cervical intraepithelial lesion grade 3 or worse in women living with HIV who were baseline HPV negative at 3 year interval screening

时间窗: 5 years

Quantify the incidence of cervical intraepithelial lesion grade 3 or worse in women living with HIV who were baseline HPV positive but with benign pathology at 2 year interval screening

时间窗: 5 years

Analyze the cost of two-stage cervical cancer screening algorithms using high-risk HPV testing in Botswana.

时间窗: 5 years

Quantify the incidence of cervical intraepithelial lesion grade 2 or worse in women living with HIV who were baseline HPV positive but with benign pathology at 2 year interval screening

时间窗: 5 years

Quantify the incidence of cervical intraepithelial lesion grade 2 or worse in women living with HIV who were baseline HPV negative at 3 year interval screening

时间窗: 5 years

Compare the sensitivity, specificity, PPV and NPV of triage of primary human papillomavirus testing with 8-type HPV genotype restriction to visual inspection with acetic acid and colposcopy

时间窗: 3 years

次要结局

  • Understand in-depth the attitudes, acceptability and preferences regarding cervical cancer screening, HPV testing, and self-sampling, for women in Botswana through interviews of a sub-set of women recruited for the cervical cancer screening study.(6 years)
  • Evaluate the performance of a novel HPV assay as a stand-alone screening tool in our high-prevalence HIV population(3 years)
  • Evaluate the impact of patient characteristics and and risk factors on the risk for cervical disease(5 years)
  • Evaluate the impact of patient demographic and clinical factors, such as number of sexual partners, smoking, HIV status and related HIV immune markers, on risk of cervical dysplasia(5 years)
  • Evaluate the impact of patient characteristics and and risk factors on the incidence of cervical dysplasia(5 years)

研究点 (1)

Loading locations...

相似试验

Unknown
不适用
Triage Strategies in Cervical Cancer PreventionCervical CancerIntraepithelial Neoplasia
NCT02510027Instituto Nacional de Salud Publica, Mexico100,000
已完成
不适用
Results Comparison of Cervical Cancer Early Detection Using Cerviray With VIA TestCervical Cancer
NCT06518070Universitas Padjadjaran44
已完成
不适用
Cervical Cancer Prevention: From DNA to mRNA? - New Technologies for Cervical Cancer Screening 2Precancerous ConditionsNeoplasms
NCT01837693Azienda USL Reggio Emilia - IRCCS41,127
进行中(未招募)
不适用
Cervical Cancer Screening With Human Papillomavirus TestingCIN3CIN2Cervical Cancer
NCT01881659International Agency for Research on Cancer50,000
进行中(未招募)
不适用
Primary Cervical Cancer Screening by Self-sampling HPV TestHuman Papillomavirus InfectionCervical CancerNegative For Intraepithelial Lesion Or MalignancyAtypical Squamous Cells of Undetermined SignificanceAtypical Squamous Cells, Cannot Rule Out High-grade Squamous Intraepithelial LesionCervical Squamous Intraepithelial LesionLow-Grade Squamous Intraepithelial LesionsHigh-Grade Squamous Intraepithelial LesionsCervical Intraepithelial Neoplasia Grade ICervical Intraepithelial Neoplasia Grade IICervical Intraepithelial Neoplasia, Grade IIIAtypical Glandular CellsAtypical Glandular Cells Not Otherwise SpecifiedAtypical Glandular Cells, Favor NeoplasticCervical Squamous Cell CarcinomaAdenocarcinoma in SituCervical Adenocarcinoma
NCT05613283Peking University People's Hospital17,875